Wheaton Joins the Duran Group

/0 Comments/in , /by

Frankfurt, Germany 9/15/15; Millville, NJ 9/15/15—Duran Group, a portfolio of companies advised by One Equity Partners Capital Advisors (OEP), has acquired laboratory glassware supplier Wheaton from Incline Equity Partners for an undisclosed amount. Wheaton provides glassware and plasticware in North America for life science R&D, IVD and medical packaging. Earlier this year, One Equity closed […]

Read more →

Agilent Buys Seahorse for $235 Million

/0 Comments/in , , /by

Santa Clara, CA and Billerica, MA 9/9/15—Agilent Technologies has definitively agreed to acquire Seahorse Bioscience for $235 million in cash. Seahorse provides instruments and assay kits for measuring cell metabolism and bioenergetics. Founded in 2001 and employing nearly 200 people, Seahorse is expected to generate $49 million in fiscal 2015 revenues. “Seahorse Bioscience’s unique technology […]

Read more →

Drug Companies Expand with New Labs

/0 Comments/in , /by

The second of IBO’s biannual features on new labs highlights facilities from the academic, government and industrial sectors, spanning a variety of disciplines. The table on page 6 lists some of the largest planned academic lab buildings as well as facilities for drug development. Also featured in this article are labs for agriculture, disease and […]

Read more →

MRM-MS Moves Toward the Clinic

/0 Comments/in /by

Tremendous progress has been made in using multiple reaction monitoring MS (MRM-MS) for verification of clinical biomarkers, for which it is widely used and accepted. Targeted proteomics, in which a subset of candidate biomarkers are detected and measured, using MRM-MS enables multiplex, high-throughput quantification from a few up to hundreds of proteins per sample, reducing […]

Read more →